What are the possible causes of vertigo two months after transcatheter aortic valve implantation (TAVI)?

Causes of Vertigo 2 Months Post-TAVI

Vertigo occurring 2 months after TAVI is most likely related to delayed cerebrovascular events, new-onset atrial fibrillation with thromboembolism, or unrelated peripheral vestibular causes, rather than acute procedural complications.

High-Risk Period for Cerebrovascular Events

The risk of cerebrovascular events (CeV) remains elevated for up to 2 months following TAVI, not just in the immediate periprocedural period 1. While the incidence is highest within the first 24 hours, this elevated risk persists through the first 2 months post-procedure 1. More than half of strokes after TAVI occur beyond 24 hours, with 58% classified as delayed (>24 hours after the procedure) 2.

Primary Causes to Consider

Thromboembolic Stroke

• New-onset atrial fibrillation is a critical cause, associated with a 4.4-fold increased risk of stroke after TAVI 2
• Atrial fibrillation occurs in up to 8.6% of patients as a new diagnosis post-TAVI, though over 25% have pre-existing AF 3
• Continuous ECG monitoring should have been performed for at least 3 days post-procedure, but delayed AF can occur 3
• Patients with a prior history of cerebrovascular disease have a 4.23-fold increased risk of recurrent events (hazard ratio: 4.23,95% CI: 1.60 to 11.11) 1

Valve-Related Thrombosis

• Leaflet thrombosis can develop after TAVI and may cause embolic events 4
• This is detectable on echocardiography as an increase in mean gradient >10 mm Hg over the first year 4
• Anticoagulation with warfarin may be more effective than direct oral anticoagulants for preventing death, myocardial infarction, and cerebrovascular events in TAVI patients 4

Paravalvular Leak Complications

• Paravalvular regurgitation occurs in up to 75% of patients at 1 year, with one-third having more than mild regurgitation 5
• While primarily causing hemodynamic issues, significant paravalvular leak can contribute to altered flow dynamics and potential thrombus formation 5

Diagnostic Evaluation Required

Immediate Workup

• Brain imaging (MRI with diffusion-weighted imaging preferred over CT) to detect acute or subacute infarction 3
• Vascular imaging to evaluate for extracranial carotid or vertebral stenosis or intracranial occlusive disease 3
• Echocardiography to assess for intracardiac thrombus, valve function, and paravalvular leak 3
• Extended cardiac monitoring (Holter or event monitor) to detect paroxysmal atrial fibrillation 3
• ECG to document any new conduction abnormalities or atrial fibrillation 3

Key Imaging Findings

• Cortical infarcts suggest embolic etiology (42% of stroke cases) 2
• Lacunar infarcts may indicate small vessel disease (26% of cases) 2
• Note that 26% of patients with clinical stroke may have no abnormalities on initial brain CT 2

Management Based on Etiology

If Atrial Fibrillation Detected

• Institute oral anticoagulation program immediately 3
• Warfarin is preferred over direct oral anticoagulants in TAVI patients with anticoagulation indications 4
• Continue low-dose aspirin (81 mg) if already on anticoagulation, though avoid multiple anticoagulant therapies when possible 3

If Intracardiac Thrombus Present

• Early institution of heparin followed by oral anticoagulants 3
• Warfarin targeting INR 2.0-3.0 is the standard approach 4

If No Cardiac Source Identified

• Long-term antiplatelet therapy with aspirin, extended-release dipyridamole, or clopidogrel 3
• Continue surveillance for delayed atrial fibrillation or other cardiac sources 6

Non-Cardiac Causes to Exclude

Peripheral Vestibular Disorders

• Benign paroxysmal positional vertigo (BPPV) can occur independently of TAVI 7
• Vestibular neuritis or labyrinthitis are common causes of vertigo in elderly patients 7
• These diagnoses require specific bedside testing (Dix-Hallpike maneuver) and typically do not require neuroimaging unless atypical features present 7

Vertebrobasilar Insufficiency

• Can present with episodic vertigo in elderly patients with vascular risk factors 7
• May require conventional angiography for dynamic evaluation if positional insufficiency suspected 7

Critical Pitfalls to Avoid

• Do not assume all vertigo at 2 months is unrelated to TAVI - the elevated cerebrovascular risk extends through this period 1
• Do not rely solely on initial post-procedure monitoring - delayed conduction abnormalities and atrial fibrillation can occur beyond the typical 3-7 day monitoring period 8
• Do not dismiss symptoms in patients with prior cerebrovascular disease - they have significantly elevated risk of recurrent events 1
• Do not use CT alone for stroke evaluation - MRI with DWI is more sensitive for detecting acute ischemic changes 7

Follow-Up Considerations

Patients should have ongoing cardiology follow-up with periodic echocardiography and ECG monitoring beyond the standard 30-day post-TAVI evaluation 6. The primary cardiologist should maintain surveillance for late procedural-related complications, including delayed cerebrovascular events and arrhythmias 3.